Development of vaccines against visceral leishmaniasis

Journal of Tropical Medicine

Volumn , Issue , 2012, Pages

  Evans, Krystal J ^a   Kedzierski, Lukasz ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BCG VACCINE; DNA VACCINE; IMMUNOLOGICAL ADJUVANT; LEISH 111F VACCINE; LEISHMANIA VACCINE; LIVE VACCINE; PARASITE ANTIGEN; PHOSPHORYL LIPID A; QUIL A; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AIDS RELATED COMPLEX; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SYNTHESIS; ENDEMIC DISEASE; FATALITY; HUMAN; INNATE IMMUNITY; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; MORTALITY; NONHUMAN; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REINFECTION; REVIEW; SYMPTOMATOLOGY; VACCINE PRODUCTION; VISCERAL LEISHMANIASIS;

EID: 81555207189     PISSN: 16879686     EISSN: 16879694     Source Type: Journal    
DOI: 10.1155/2012/892817     Document Type: Review

References (154)

1. Mauricio I. L., Stothard J. R., Miles M. A., The strange case of Leishmania chagasi Parasitology Today 2000 16 5 188 189 (Pubitemid 30216562)
2. Leclercq V., Lebastard M., Belkaid Y., Louis J., Milon G., The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci The Journal of Immunology 1996 157 10 4537 4545 (Pubitemid 126449375)
3. Alvar J., Yactayo S., Bern C., Leishmaniasis and poverty Trends in Parasitology 2006 22 12 552 557 (Pubitemid 44716723)
4. Stanley A. C., Engwerda C. R., Balancing immunity and pathology in visceral leishmaniasis Immunology and Cell Biology 2007 85 2 138 147 (Pubitemid 46398719)
5. Kaye P. M., Svensson M., Ato M., Maroof A., Polley R., Stager S., Zubairi S., Engwerda C. R., The immunopathology of experimental visceral leishmaniasis Immunological Reviews 2004 201 239 253 (Pubitemid 39318456)
6. Kharazmi A., Kemp K., Ismail A., Gasim S., Gaafar A., Kurtzhals J. A. L., El Hassan A. M., Theander T. G., Kemp M., T-cell response in human leishmaniasis Immunology Letters 1999 65 1-2 105 108 (Pubitemid 29074508)
7. Stern J. J., Oca M. J., Rubin B. Y., Anderson S. L., Murray H. W., Role of L3T4+ and Lyt-2+ cells in experimental visceral leishmaniasis The Journal of Immunology 1988 140 11 3971 3977
8. Stager S., Smith D. F., Kaye P. M., Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis The Journal of Immunology 2000 165 12 7064 7071 (Pubitemid 32001180)
9. Dantas-Torres F., Canine leishmaniosis in South America Parasites and Vectors 2009 2 1, article S1
10. Lima L. V. R., Carneiro L. A., Campos M. B., Chagas E. J., Laurenti M. D., Corbett C. E. P., Lainson R., Silveira F. T., Canine visceral leishmaniasis due to Leishmania (L.) infantum chagasi in Amazonian Brazil: comparison of the parasite density from the skin, lymph node and visceral tissues between symptomatic and asymptomatic, seropositive dogs Revista do Instituto de Medicina Tropical de Sao Paulo 2010 52 5 259 265
11. Peacock C. S., Seeger K., Harris D., Murphy L., Ruiz J. C., Quail M. A., Peters N., Adlem E., Tivey A., Aslett M., Kerhornou A., Ivens A., Fraser A., Rajandream M. A., Carver T., Norbertczak H., Chillingworth T., Hance Z., Jagels K., Moule S., Ormond D., Rutter S., Squares R., Whitehead S., Rabbinowitsch E., Arrowsmith C., White B., Thurston S., Bringaud F., Baldauf S. L., Faulconbridge A., Jeffares D., Depledge D. P., Oyola S. O., Hilley J. D., Brito L. O., Tosi L. R. O., Barrell B., Cruz A. K., Mottram J. C., Smith D. F., Berriman M., Comparative genomic analysis of three Leishmania species that cause diverse human disease Nature Genetics 2007 39 7 839 847 (Pubitemid 47014491)
12. Lainson R., Shaw J. J., Leishmaniasis in Brazil:XII. Observations on cross immunity in monkeys and man infected with Leishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guyanensis and L. b. panamensis Journal of Tropical Medicine and Hygiene 1977 80 2 29 35 (Pubitemid 8114769)
13. Porrozzi R., Teva A., Amaral V. F., Santos da Costa M. V., Grimaldi G., Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta) American Journal of Tropical Medicine and Hygiene 2004 71 3 297 305 (Pubitemid 39232120)
14. Garg R., Dube A., Animal models for vaccine studies for visceral leishmaniasis Indian Journal of Medical Research 2006 123 3 439 454 (Pubitemid 43905581)
15. Nylen S., Gautam S., Immunological perspectives of leishmaniasis Journal of Global Infectious Diseases 2010 2 135 146
16. Khamesipour A., Dowlati Y., Asilian A., Hashemi-Fesharki R., Javadi A., Noazin S., Modabber F., Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis Vaccine 2005 23 28 3642 3648 (Pubitemid 40692409)
17. Nadim A., Javadian E., Tahvildar-Bidruni G., Ghorbani M., Effectiveness of leishmanization in the control of cutaneous leishmaniasis Bulletin de la Société de Pathologie Exotique et de ses Filiales 1983 76 4 377 383 (Pubitemid 14229645)
18. Modabber F., Leishmaniasis vaccines: past, present and future International Journal of Antimicrobial Agents 2010 36 1 S58 S61
19. Handman E., Leishmaniasis: current status of vaccine development Clinical Microbiology Reviews 2001 14 2 229 243 (Pubitemid 32294669)
20. Serebriakov V. A., Karakhodzhaeva S., Dzhumaev M. D., Effect of leishmanial vaccinations on the dynamics of immunity to diphtheria in conditions of secondary revaccination with adsorbed pertussis-diphtheria-tetanus vaccine Meditsinskaya Parazitologiya i Parazitarnye Bolezni 1972 41 3 303 307
21. Gafurov I. M., Experience in controlling and preventing zoonotic cutaneous leishmaniasis in Uzbekistan Meditsinskaia Parazitologiia i Parazitarnye Bolezni 1999 1 58 59
22. Tabbara K. S., Peters N. C., Afrin F., Mendez S., Bertholet S., Belkaid Y., Sacks D. L., Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection Infection and Immunity 2005 73 8 4714 4722 (Pubitemid 41105627)
23. Noazin S., Modabber F., Khamesipour A., Smith P. G., Moulton L. H., Nasseri K., Sharifi I., Khalil E. A. G., Bernal I. D. V., Antunes C. M. F., Kieny M. P., Tanner M., First generation leishmaniasis vaccines: a review of field efficacy trials Vaccine 2008 26 52 6759 6767
24. Noazin S., Khamesipour A., Moulton L. H., Tanner M., Nasseri K., Modabber F., Sharifi I., Khalil E. A. G., Bernal I. D. V., Antunes C. M. F., Smith P. G., Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasisa meta-analysis Vaccine 2009 27 35 4747 4753
25. Khalil E. A. G., Ayed N. B., Musa A. M., Ibrahim M. E., Mukhtar M. M., Zijlstra E. E., Elhassan I. M., Smith P. G., Kieny P. M., Ghalib H. W., Zicker F., Modabber F., Elhassan A. M., Dichotomy of protective cellular immune responses to human visceral leishmaniasis Clinical and Experimental Immunology 2005 140 2 349 353 (Pubitemid 40559163)
26. Musa A. M., Khalil E. A. G., Mahgoub F. A. E., Elgawi S. H. H., Modabber F., Elkadaru A. E. M. Y., Aboud M. H., Noazin S., Ghalib H. W., El-Hassan A. M., Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment Transactions of the Royal Society of Tropical Medicine and Hygiene 2008 102 1 58 63 (Pubitemid 350177425)
27. Ghalib H., Modabber F., Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis Kinetoplastid Biology and Disease 2007 6, article 7
28. Bhaumik S. K., Naskar K., De T., Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10 European Journal of Immunology 2009 39 8 2146 2160
29. Bourdoiseau G., Hugnet C., Gonalves R. B., Vézilier F., Petit-Didier E., Papierok G., Lemesre J. L., Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs Veterinary Immunology and Immunopathology 2009 128 13 71 78
30. Hommel M., Jaffe C. L., Travi B., Milon G., Experimental models for leishmaniasis and for testing anti-leishmanial vaccines Annals of Tropical Medicine and Parasitology 1995 89 1 55 73 (Pubitemid 26030069)
31. Requena J. M., Soto M., Doria M. D., Alonso C., Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model Veterinary Immunology and Immunopathology 2000 76 3-4 269 281
32. Tesh R. B., Control of zoonotic visceral leishmaniasis: is it time to change strategies? American Journal of Tropical Medicine and Hygiene 1995 52 3 287 292
33. Rodrguez-Cortés A., Ojeda A., Lpez-Fuertes L., Timn M., Altet L., Solano-Gallego L., Snchez-Robert E., Francino O., Alberola J., Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge Vaccine 2007 25 46 7962 7971 (Pubitemid 47632977)
34. Carrin J., Folgueira C., Alonso C., Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells Vaccine 2008 26 20 2537 2544
35. Dondji B., Pérez-Jimenez E., Goldsmith-Pestana K., Esteban M., McMahon-Pratt D., Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis Infection and Immunity 2005 73 8 5286 5289 (Pubitemid 41105698)
36. Marques-da-Silva E. A., Coelho E. A. F., Gomes D. C. O., Vilela M. C., Masioli C. Z., Tavares C. A. P., Fernandes A. P., Afonso L. C. C., Rezende S. A., Intramuscular immunization with p36(LACK) DNA vaccine induces IFN- production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge Parasitology Research 2005 98 1 67 74 (Pubitemid 41670563)
37. Gomes D. C., Pinto E. F., de Melo L. D., Lima W. P., Larraga V., Lopes U. G., Rossi-Bergmann B., Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice Vaccine 2007 25 12 2168 2172 (Pubitemid 46227690)
38. Ramiro M. J., Zrate J. J., Hanke T., Rodriguez D., Rodriguez J. R., Esteban M., Lucientes J., Castillo J. A., Larraga V., Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK Vaccine 2003 21 19-20 2474 2484 (Pubitemid 36561339)
39. Ramos I., Alonso A., Marcen J. M., Peris A., Castillo J. A., Colmenares M., Larraga V., Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response Vaccine 2008 26 3 333 344
40. Rafati S., Zahedifard F., Nazgouee F., Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis Vaccine 2006 24 12 2169 2175 (Pubitemid 43255160)
41. Rafati S., Nakhaee A., Taheri T., Taslimi Y., Darabi H., Eravani D., Sanos S., Kaye P., Taghikhani M., Jamshidi S., Rad M. A., Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum Vaccine 2005 23 28 3716 3725 (Pubitemid 40692418)
42. Rafati S., Zahedifard F., Azari M. K., Taslimi Y., Taheri T., Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice Experimental Parasitology 2008 118 3 393 401
43. Khoshgoo N., Zahedifard F., Azizi H., Taslimi Y., Alonso M. J., Rafati S., Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals Vaccine 2008 26 46 5822 5829
44. Wilson M. E., Young B. M., Andersen K. P., Weinstock J. V., Metwali A., Ali K. M., Donelson J. E., A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice Infection and Immunity 1995 63 5 2062 2069
45. Streit J. A., Recker T. J., Donelson J. E., Wilson M. E., BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice Experimental Parasitology 2000 94 1 33 41 (Pubitemid 30062518)
46. Fragaki K., Suffia I., Ferrua B., Rousseau D., Le Fichoux Y., Kubar J., Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters Vaccine 2001 19 13-14 1701 1709 (Pubitemid 32175731)
47. Aguilar-Be I., da Silva Zardo R., Paraguai De Souza E., Borja-Cabrera G. P., Rosado-Vallado M., Mut-Martin M., Garca-Miss M. D. R., Palatnik De Sousa C. B., Dumonteil E., Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis Infection and Immunity 2005 73 2 812 819 (Pubitemid 40165737)
48. Oliveira-Freitas E., Casas C. P., Borja-Cabrera G. P., Santos F. N., Nico D., Souza L. O. P., Tinoco L. W., da Silva B. P., Palatnik M., Parente J. P., Palatnik-de-Sousa C. B., Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis Vaccine 2006 24 18 3909 3920
49. Molano I., Garca Alonso M., Mirn C., Redondo E., Requena J. M., Soto M., Gmez Nieto C., Alonso C., A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum Veterinary Immunology and Immunopathology 2003 92 1-2 1 13 (Pubitemid 36298678)
50. Parody N., Soto M., Requena J. M., lonso C., Adjuvant guided polarization of the immune humoral response against a protective multicomponent antigenic protein (Q) from Leishmania infantum. A CpG + Q mix protects Balb/c mice from infection Parasite Immunology 2004 26 6-7 283 293 (Pubitemid 39576329)
51. Fernandes A. P., Costa M. M. S., Coelho E. A. F., Michalick M. S. M., de Freitas E., Melo M. N., Luiz Tafuri W., Resende D. D. M., Hermont V., Abrantes C. D. F., Gazzinelli R. T., Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein Vaccine 2008 26 46 5888 5895
52. Zanin F. H. C., Coelho E. A. F., Tavares C. A. P., Marques-da-Silva E. A., Silva Costa M. M., Rezende S. A., Gazzinelli R. T., Fernandes A. P., Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections Microbes and Infection 2007 9 9 1070 1077 (Pubitemid 47287743)
53. Lemesre J. L., Holzmuller P., Cavaleyra M., Gonalves R. B., Hottin G., Papierok G., Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes Vaccine 2005 23 22 2825 2840 (Pubitemid 40386484)
54. Lemesre J.-L., Holzmuller P., Gonalves R. B., Bourdoiseau G., Hugnet C., Cavaleyra M., Papierok G., Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial Vaccine 2007 25 21 4223 4234 (Pubitemid 46661824)
55. Gradoni L., Foglia Manzillo V., Pagano A., Piantedosi D., De Luna R., Gramiccia M., Scalone A., Di Muccio T., Oliva G., Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals Vaccine 2005 23 45 5245 5251 (Pubitemid 41443430)
56. Coler R. N., Goto Y., Bogatzki L., Raman V., Reed S. G., Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4 + T cells Infection and Immunity 2007 75 9 4648 4654 (Pubitemid 47378126)
57. Trigo J., Abbehusen M., Netto E. M., Nakatani M., Pedral-Sampaio G., de Jesus R. S., Goto Y., Guderian J., Howard R. F., Reed S. G., Treatment of canine visceral leishmaniasis by the vaccine Leish-111f + MPL-SE Vaccine 2010 28 19 3333 3340
58. Melby P. C., Yang J., Zhao W., Perez L. E., Cheng J., Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis Infection and Immunity 2001 69 8 4719 4725 (Pubitemid 32674448)
59. Jaffe C. L., Rachamim N., Sarfstein R., Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis The Journal of Immunology 1990 144 2 699 706 (Pubitemid 20036105)
60. Ghosh A., Zhang W. W., Matlashewski G., Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections Vaccine 2001 20 1-2 59 66 (Pubitemid 32905314)
61. Ghosh A., Labrecque S., Matlashewski G., Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response Vaccine 2001 19 23-24 3169 3178 (Pubitemid 32324046)
62. Tewary P., Sukumaran B., Saxena S., Madhubala R., Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen Vaccine 2004 22 23-24 3053 3060 (Pubitemid 39037207)
63. Tewary P., Jain M., Sahani M. H., Saxena S., Madhubala R., A heterologous prime-boost vaccination regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral Leishmaniasis Journal of Infectious Diseases 2005 191 12 2130 2137 (Pubitemid 40800585)
64. Sukumaran B., Tewary P., Saxena S., Madhubala R., Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani Vaccine 2003 21 11-12 1292 1299 (Pubitemid 36139962)
65. Basu R., Bhaumik S., Basu J. M., Naskar K., De T., Roy S., Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis The Journal of Immunology 2005 174 11 7160 7171 (Pubitemid 40705683)
66. Bhaumik S., Basu R., Sen S., Naskar K., Roy S., KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major Vaccine 2009 27 9 1306 1316
67. McSorley S. J., Xu D., Liew F. Y., Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters Infection and Immunity 1997 65 1 171 178 (Pubitemid 27008919)
68. Bhowmick S., Ravindran R., Ali N., Gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani Infection and Immunity 2008 76 3 1003 1015 (Pubitemid 351428060)
69. Bhowmick S., Ravindran R., Ali N., Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response Vaccine 2007 25 35 6544 6556 (Pubitemid 47198915)
70. Tewary P., Mehta J., Sukumaran B., Madhubala R., Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection FEMS Immunology and Medical Microbiology 2004 42 2 241 248 (Pubitemid 39208553)
71. Bhowmick S., Ali N., Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis PLoS One 2009 4 6
72. Mazumdar T., Anam K., Ali N., A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice Vaccine 2004 22 9-10 1162 1171 (Pubitemid 38296659)
73. Bhardwaj S., Vasishta R. K., Arora S. K., Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis Experimental Parasitology 2009 121 1 29 37
74. Carter K. C., Henriquez F. L., Campbell S. A., Roberts C. W., Nok A., Mullen A. B., McFarlane E., DNA vaccination against the parasite enzyme gamma-glutamylcysteine synthetase confers protection against Leishmania donovani infection Vaccine 2007 25 22 4502 4509 (Pubitemid 46678561)
75. Palatnik-de-Sousa C. B., Paraguai-de-Souza E., Gomes E. M., Borojevic R., Experimental murine Leishmania donovani infection: immunoprotection by the fucose-mannose ligand (FML) Brazilian Journal of Medical and Biological Research 1994 27 2 547 551
76. Santos W. R., Paraguai de Souza E., Palatnik M., Palatnik de Sousa C. B., Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani Vaccine 1999 17 20-21 2554 2561 (Pubitemid 29314448)
77. Borja-Cabrera G. P., Correia Pontes N. N., da Silva V. O., Paraguai de Souza E., Santos W. R., Gomes E. M., Luz K. G., Palatnik M., Palatnik De Sousa C. B., Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (So Gonalo do Amarante, RN) Vaccine 2002 20 27-28 3277 3284 (Pubitemid 35251815)
78. Saraiva E. M., de Figueiredo Barbosa A., Santos F. N., Borja-Cabrera G. P., Nico D., Souza L. O. P., Mendes-Aguiar C. D. O., De Souza E. P., Fampa P., Parra L. E., Menz I., Dias J. G., De Oliveira S. M., Palatnik-De-Sousa C. B., The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine Vaccine 2006 24 13 2423 2431 (Pubitemid 43290426)
79. Nogueira F. S., Moreira M. A. B., Borja-Cabrera G. P., Santos F. N., Menz I., Parra L. E., Xu Z., Chu H. J., Palatnik-de-Sousa C. B., Luvizotto M. C. R., Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs Vaccine 2005 23 40 4805 4810 (Pubitemid 41242874)
80. Saldarriaga O. A., Travi B. L., Park W., Perez L. E., Melby P. C., Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs Vaccine 2006 24 11 1928 1940 (Pubitemid 43238276)
81. Tonui W. K., Mpoke S. S., Orago A. S., Turco S. J., Mbati P. A., Mkoji G. M., Leishmania donovani -derived lipophosphoglycan plus BCG induces a Th1 type immune response but does not protect Syrian golden hamsters (Mesocricetus auratus) and BALB/c mice against Leishmania donovani Onderstepoort Journal of Veterinary Research 2003 70 4 255 263 (Pubitemid 38353256)
82. Rachamim N., Jaffe C. L., Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis The Journal of Immunology 1993 150 6 2322 2331 (Pubitemid 23127477)
83. Coler R. N., Reed S. G., Second-generation vaccines against leishmaniasis Trends in Parasitology 2005 21 5 244 249 (Pubitemid 40544642)
84. Bertholet S., Goto Y., Carter L., Bhatia A., Howard R. F., Carter D., Coler R. N., Vedvick T. S., Reed S. G., Optimized subunit vaccine protects against experimental leishmaniasis Vaccine 2009 27 50 7036 7045
85. Chakravarty J., Kumar S., Trivedi S., Rai V. K., Singh A., Ashman J. A., Laughlin E. M., Coler R. N., Kahn S. J., Beckmann A. M., Cowgill K. D., Reed S. G., Sundar S., Piazza F. M., A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis Vaccine 2011 29 19 3531 3537
86. Gurunathan S., Klinman D. M., Seder R. A., DNA vaccines: immunology, application, and optimization Annual Review of Immunology 2000 18 927 974 (Pubitemid 30365401)
87. Rodrigues M. M., Boscardin S. B., Vasconcelos J. R., Hiyane M. I., Salay G., Soares I. S., Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines Anais da Academia Brasileira de Ciencias 2003 75 4 443 468 (Pubitemid 37445843)
88. Suffia I., Ferrua B., Stien X., Mograbi B., Marty P., Rousseau D., Fragaki K., Kubar J., A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis Infection and Immunity 2000 68 2 630 636 (Pubitemid 30056516)
89. Nylén S., Sacks D., Interleukin-10 and the pathogenesis of human visceral leishmaniasis Trends in Immunology 2007 28 9 378 384 (Pubitemid 47385375)
90. Gurunathan S., Sacks D. L., Brown D. R., Reiner S. L., Charest H., Glaichenhaus N., Seder R. A., Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major Journal of Experimental Medicine 1997 186 7 1137 1147 (Pubitemid 27441157)
91. Gurunathan S., Prussin C., Sacks D. L., Seder R. A., Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection Nature Medicine 1998 4 12 1409 1415 (Pubitemid 28553464)
92. Gurunathan S., Stobie L., Prussin C., Sacks D. L., Glaichenhaus N., Fowell D. J., Locksley R. M., Chang J. T., Wu C. Y., Seder R. A., Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8 + T cells The Journal of Immunology 2000 165 2 915 924 (Pubitemid 30484759)
93. Gonzalo R. M., Del Real G., Rodriguez J. R., Rodriguez D., Heljasvaara R., Lucas P., Larraga V., Esteban M., A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis Vaccine 2002 20 7-8 1226 1231 (Pubitemid 34135960)
94. Rafati S., Fasel N., Masina S., Leishmania cysteine proteinases: from gene to subunit vaccine Current Genomics 2003 4 3 253 261 (Pubitemid 36348202)
95. Mazumder S., Maji M., Das A., Ali N., Potency, efficacy and durability of DNA/DNA, DNA/ protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice PLoS One 2011 6 2
96. Sinha S., Sundaram S., Singh A. P., Tripathi A., A gp63 based vaccine candidate against Visceral Leishmaniasis Bioinformation 2001 5 8 320 325
97. Moll H., Berberich C., Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis Immunobiology 2001 204 5 659 666 (Pubitemid 34134180)
98. Brandonisio O., Spinelli R., Pepe M., Dendritic cells in Leishmania infection Microbes and Infection 2004 6 15 1402 1409 (Pubitemid 41110584)
99. Vanloubbeeck Y. F., Ramer A. E., Jie F., Jones D. E., CD4 + Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing Infection and Immunity 2004 72 8 4455 4463 (Pubitemid 38989302)
100. Ahuja S. S., Reddick R. L., Sato N., Montalbo E., Kostecki V., Zhao W., Dolan M. J., Melby P. C., Ahuja S. K., Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection The Journal of Immunology 1999 163 7 3890 3897 (Pubitemid 29450916)
101. Ghosh M., Pal C., Ray M., Maitra S., Mandal L., Bandyopadhyay S., Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis The Journal of Immunology 2003 170 11 5625 5629 (Pubitemid 36617853)
102. Moore E. M., Lockwood D. N., Treatment of visceral leishmaniasis Journal of Global Infectious Diseases 2010 2 151 158
103. Bhowmick S., Mazumdar T., Sinha R., Ali N., Comparison of liposome based antigen delivery systems for protection against Leishmania donovani Journal of Controlled Release 2010 141 2 199 207
104. Henriquez F. L., Campbell S. A., Roberts C. W., Mullen A. B., Burchmore R., Carter K. C., Vaccination with recombinant Leishmania donovani gamma-glutamylcysteine synthetase fusion protein protects against L. donovani infection Journal of Parasitology 2010 96 5 929 936
105. Peters N. C., Kimblin N., Secundino N., Kamhawi S., Lawyer P., Sacks D. L., Vector transmission of Leishmania abrogates vaccine-induced protective immunity PLoS Pathogens 2009 5 6
106. Gomes R. B., Brodskyn C., de Oliveira C. I., Costa J., Miranda J. C., Caldas A., Valenzuela J. G., Barral-Netto M., Barral A., Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti- Leishmania chagasi delayed-type hypersensitivity Journal of Infectious Diseases 2002 186 10 1530 1534 (Pubitemid 35286128)
107. Fishbein D. B., Robinson L. E., Rabies The New England Journal of Medicine 1993 329 22 1632 1638 (Pubitemid 23345644)
108. Sauret J. M., Vilissova N., Human brucellosis Journal of the American Board of Family Practice 2002 15 5 401 406 (Pubitemid 44867116)
109. Postigo J. A. R., Leishmaniasis in the World Health Organization Eastern Mediterranean Region International Journal of Antimicrobial Agents 2010 36 1 S62 S65
110. Ashford R. W., The leishmaniases as emerging and reemerging zoonoses International Journal for Parasitology 2000 30 12-13 1269 1281
111. Biglino A., Bolla C., Concialdi E., Trisciuoglio A., Romano A., Ferroglio E., Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic Journal of Clinical Microbiology 2010 48 1 131 136
112. Schantz P. M., Steurer F. J., Duprey Z. H., Kurpel K. P., Barr S. C., Jackson J. E., Breitschwerdt E. B., Levy M. G., Fox J. C., Autochthonous visceral leishmaniasis in dogs in North America Journal of the American Veterinary Medical Association 2005 226 8 1316 1322 (Pubitemid 40524729)
113. Ready P. D., Leishmaniasis emergence in Europe Euro Surveillance 2010 15 10 19505
114. Baneth G., Shaw S. E., Chemotherapy of canine leishmaniosis Veterinary Parasitology 2002 106 4 315 324 (Pubitemid 34655456)
115. Palatnik-de-Sousa C. B., dos Santos W. R., Frana-Silva J. C., Da Costa R. T., Barbosa Reis A., Palatnik M., Mayrink W., Genaro O., Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil American Journal of Tropical Medicine and Hygiene 2001 65 5 510 517 (Pubitemid 33138167)
116. Reithinger R., Coleman P. G., Alexander B., Vieira E. P., Assis G., Davies C. R., Are insecticide-impregnated dog collars a feasible alternative to dog culling as a strategy for controlling canine visceral leishmaniasis in Brazil? International Journal for Parasitology 2004 34 1 55 62 (Pubitemid 38056614)
117. Courtenay O., Quinnell R. J., Garcez L. M., Shaw J. J., Dye C., Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission Journal of Infectious Diseases 2002 186 9 1314 1320 (Pubitemid 35193010)
118. Boggiatto P. M., Ramer-Tait A. E., Metz K., Kramer E. E., Gibson-Corley K., Mullin K., Hostetter J. M., Gallup J. M., Jones D. E., Petersen C. A., Immunologic indicators of clinical progression during canine Leishmania infantum infection Clinical and Vaccine Immunology 2010 17 2 267 273
119. Poot J., Janssen L. H. M., van Kasteren-Westerneng T. J., van der Heijden-Liefkens K. H. A., Schijns V. E. J. C., Heckeroth A., Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants Vaccine 2009 27 33 4439 4446
120. Bahia D., Gontijo N. F., Len I. R., Perales J., Pereira M. H., Oliveira G., Corra-Oliveira R., Reis A. B., Antibodies from dogs with canine visceral leishmaniasis recognise two proteins from the saliva of Lutzomyia longipalpis Parasitology Research 2007 100 3 449 454 (Pubitemid 46011253)
121. Giunchetti R. C., Corra-Oliveira R., Martins-Filho O. A., Teixeira-Carvalho A., Roatt B. M., Aguiar-Soares R. D. D. O., Coura-Vital W., Abreu R. T. D., Malaquias L. C. C., Gontijo N. F., Brodskyn C., Oliveira C. I. D., Costa D. J., de Lana M., Reis A. B., A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs Vaccine 2008 26 5 623 638
122. Gomes R., Teixeira C., Teixeira M. J., Oliveira F., Menezes M. J., Silva C., De Oliveira C. I., Miranda J. C., Elnaiem D. E., Kamhawi S., Valenzuela J. G., Brodskyn C. I., Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model Proceedings of the National Academy of Sciences of the United States of America 2008 105 22 7845 7850 (Pubitemid 351872726)
123. Collin N., Gomes R., Teixeira C., Cheng L., Laughinghouse A., Ward J. M., Elnaiem D. E., Fischer L., Valenzuela J. G., Kamhawi S., Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania PLoS Pathogens 2009 5 5
124. Dantas-Torres F., Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a
125. Palatnik-de-Sousa C. B., Dutra H. S., Borojevic R., Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the Fucose-Mannose Ligand (FML) Acta Tropica 1993 53 1 59 72 (Pubitemid 23113698)
126. da Silva V. O., Borja-Cabrera G. P., Correia Pontes N. N., de Souza E. P., Luz K. G., Palatnik M., Palatnik De Sousa C. B., A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (So Gonalo do Amaranto, RN) Vaccine 2000 19 9-10 1082 1092 (Pubitemid 32008272)
127. Borja-Cabrera G. P., Mendes A. C., Paraguai de Souza E., Okada L. Y. H., Trivellato F. A. D. A., Kawasaki J. K. A., Costa A. C., Reis A. B., Genaro O., Batista L. M. M., Palatnik M., Palatnik-De-Sousa C. B., Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine Vaccine 2004 22 17-18 2234 2243 (Pubitemid 38656119)
128. Borja-Cabrera G. P., Santos F. N., Santos F. B., Trivellato F. A. D. A., Kawasaki J. K. A., Costa A. C., Castro T., Nogueira F. S., Moreira M. A. B., Luvizotto M. C. R., Palatnik M., Palatnik-de-Sousa C. B., Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis Vaccine 2010 28 3 597 603
129. Palatnik-de-Sousa C. B., Silva-Antunes I., Morgado Ade A., Menz I., Palatnik M., Lavor C., Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas Vaccine 2009 27 27 3505 3512
130. Resende D. M., Caetano B. C., Dutra M. S., Penido M. L. O., Abrantes C. F., Verly R. M., Resende J. M., Pil-Veloso D., Rezende S. A., Bruna-Romero O., Fernandes A. P., Gazzinelli R. T., Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN- and cytolytic activity by CD8 + T cells Vaccine 2008 26 35 4585 4593
131. Daneshvar H., Molaei M. M., Kamiabi H., Burchmore R., Hagan P., Phillips R. S., Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis Parasite Immunology 2010 32 11-12 722 730
132. Mitchell G. F., Handman E., Spithill T. W., Vaccination against cutaneous Leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection Australian Journal of Experimental Biology and Medical Science 1984 62 2 145 153 (Pubitemid 14058198)
133. Daneshvar H., Coombs G. H., Hagan P., Phillips R. S., Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines Journal of Infectious Diseases 2003 187 10 1662 1668 (Pubitemid 36578973)
134. Aebischer T., Morris L., Handman E., Intravenous injection of irradiated Leishmania major into susceptible BALB/c mice: immunization or protective tolerance International Immunology 1994 6 10 1535 1543 (Pubitemid 24317862)
135. Gorczynski R. M., Immunization of susceptible BALB/c mice against Leishmania braziliensis. II. Use of temperature-sensitive avirulent clones of parasite for vaccination purposes Cellular Immunology 1985 94 1 11 20 (Pubitemid 15247791)
136. Beverley S. M., Protozomics: trypanosomatid parasite genetics comes of age Nature Reviews Genetics 2003 4 1 11 19 (Pubitemid 36043211)
137. Titus R. G., Gueiros-Filho F. J., de Freitas L. A. R., Beverley S. M., Development of a safe live Leishmania vaccine line by gene replacement Proceedings of the National Academy of Sciences of the United States of America 1995 92 22 10267 10271
138. Amaral V. F., Teva A., Oliveira-Neto M. P., Silva A. J., Pereira M. S., Cupolillo E., Porrozzi R., Coutinho S. G., Pirmez C., Beverley S. M., Grimaldi G., Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease Memorias do Instituto Oswaldo Cruz 2002 97 7 1041 1048 (Pubitemid 135747502)
139. Muyombwe A., Olivier M., Ouellette M., Papadopoulou B., Selective killing of Leishmania amastigotes expressing a thymidine kinase suicide gene Experimental Parasitology 1997 85 1 35 42 (Pubitemid 27236712)
140. Davoudi N., Tate C. A., Warburton C., Murray A., Mahboudi F., McMaster W. R., Development of a recombinant Leishmania major strain sensitive to ganciclovir and 5-fluorocytosine for use as a live vaccine challenge in clinical trials Vaccine 2005 23 9 1170 1177 (Pubitemid 40052013)
141. Sah J. F., Ito H., Kolli B. K., Peterson D. A., Sassa S., Chang K. P., Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy Journal of Biological Chemistry 2002 277 17 14902 14909 (Pubitemid 34952564)
142. Kumari S., Samani M., Khare P., Misra P., Dutta S., Kolli B. K., Sharma S., Chang K. P., Dube A., Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis European Journal of Immunology 2009 39 1 178 191
143. Ouellette M., Drummelsmith J., El Fadili A., Kndig C., Richard D., Roy G., Pterin transport and metabolism in Leishmania and related trypanosomatid parasites International Journal for Parasitology 2002 32 4 385 398 (Pubitemid 34159125)
144. Papadopoulou B., Roy G., Breton M., Kndig C., Dumas C., Fillion I., Singh A. K., Olivier M., Ouellette M., Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination Infection and Immunity 2002 70 1 62 68 (Pubitemid 34028599)
145. Selvapandiyan A., Duncan R., Debrabant A., Lee N., Sreenivas G., Salotra P., Nakhasi H. L., Genetically modified live attenuated parasites as vaccines for leishmaniasis Indian Journal of Medical Research 2006 123 3 455 466 (Pubitemid 43905582)
146. Selvapandiyan A., Dey R., Nylen S., Duncan R., Sacks D., Nakhasi H. L., Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis The Journal of Immunology 2009 183 3 1813 1820
147. Silvestre R., Cordeiro-da-Silva A., Santarém N., Vergnes B., Sereno D., Ouaissi A., SIR2-deficient Leishmania infantum induces a defined IFN- /IL-10 pattern that correlates with protection The Journal of Immunology 2007 179 5 3161 3170
148. Taylor V. M., Muoz D. L., Cedeo D. L., Vélez I. D., Jones M. A., Robledo S. M., Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents Experimental Parasitology 2010 126 4 471 475
149. Breton M., Tremblay M. J., Ouellette M., Papadopoulou B., Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis Infection and Immunity 2005 73 10 6372 6382 (Pubitemid 41368798)
150. Azizi H., Hassani K., Taslimi Y., Najafabadi H. S., Papadopoulou B., Rafati S., Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae Parasitology 2009 136 7 723 735
151. Mizbani A., Taheri T., Zahedifard F., Taslimi Y., Azizi H., Azadmanesh K., Papadopoulou B., Rafati S., Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis Vaccine 2009 28 1 53 62
152. Beattie L., Evans K. J., Kaye P. M., Smith D. F., Transgenic Leishmania and the immune response to infection Parasite Immunology 2008 30 4 255 266 (Pubitemid 351347571)
153. Rapsodi against leishmaniasis. http://www.fp7-rapsodi.eu/
154. Development of a DNA vaccine for visceral leishmaniasis: LEISHDNAVAX. http://www.leishdnavax.org/